Skip to main content
Clinical Trials/NCT04106336
NCT04106336UnknownPhase 1

Cortical Excitability and Role of rTMS in Cannabis Use Disorder

Assiut University0 sites60 target enrollmentStarted: October 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Enrollment
60
Primary Endpoint
Determination of role of rTMS for reducing cannabis craving

Study Overview

Brief Summary

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •18to 50 years of age
  • •cannabis use disorder according to DSM 5 definition
  • •clear consent to participate in study

Exclusion Criteria

  • •cardiac peacemaker
  • •metal implant in the head as participate will be applied to magnetic field of TMS
  • •current intake of any medication affect cognition (as anti psychotic and anti epileptic)
  • •current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
  • •age younger than 18 and older than 50 years

Arms & Interventions

non cannabis addict

No Intervention

30 non cannabis addict will be control group

cannabis addict

Active Comparator

30 cannabis addict will undergo rTMS

Intervention: rTMS (Device)

Outcomes

Primary Outcomes

Determination of role of rTMS for reducing cannabis craving

Time Frame: 1 year

Incidenc of cannabis craving after rTMS

Secondary Outcomes

  • Estimation of cortical excitability in cannabis addict(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Asmaa Omar Radwan Helal

Asmaa Omar Radwan Helal

Assiut University

Similar Trials